Clinical Trials
11 trialsNCT04115410 2020-05-28
PD-1 Immune Checkpoint Inhibitors and Immune-Related Adverse Events: a Cohort Study
Sungkyunkwan University
Unknown
NCT03092986 2019-03-08
Outcome of Cisplatin and Vinblastine Versus Paclitaxel and Carboplatin as Sequential Chemotherapy Followed by Radiotherapy in Locally Advanced Non-small Cell Lung Cancer
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Phase 4 Completed
NCT01134861 2015-03-27
Radiation Therapy Plus Chemotherapy in Treating Patients With Non-small Cell Lung Cancer
Radiation Therapy Oncology Group
Phase 3 Completed
NCT00003240 2013-12-18
Standard Therapy Given With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00003159 2013-12-04
Surgery With or Without Preoperative Chemotherapy in Treating Patients With Resectable Non-small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00004887 2013-09-20
Paclitaxel and Carboplatin Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer That Cannot Be Removed During Surgery
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00002887 2013-09-17
Hydroxyurea Plus Combination Chemotherapy in Patients With Non-small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 1 Unknown
NCT00006212 2013-09-17
Phosphorus-32 Plus Radiation Therapy and Chemotherapy in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 1 Unknown
NCT00004209 2013-08-07
Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00002823 2013-03-28
Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3 Completed
NCT00083083 2011-03-01
Fludeoxyglucose F18 Positron Emission Tomography Imaging In Assessing Patients Before and After Treatment for Locally Advanced Non-Small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 2 Unknown